Related Experiment Video
Updated: May 24, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Characterization of putative Japanese encephalitis virus receptor molecules on microglial cells
Thananya Thongtan1, Nitwara Wikan, Phitchayapak Wintachai
1Department of Biochemistry, Chulalongkorn University, Bangkok, Thailand.
Abstract:
Japanese encephalitis virus (JEV) a mosquito-borne flavivirus is a major cause of viral encephalitis in Asia. While the principle target cells for JEV in the central nervous system are believed to be neurons, microglia are activated in response to JEV and have been proposed to act as a long lasting virus reservoir. Viral attachment to a host cell is the first step of the viral entry process and is a critical mediator of tissue tropism. This study sought to identify molecules associated with JEV entry to microglial cells. Virus overlay protein-binding assay (VOPBA) and liquid chromatography-mass spectrometry (LC/MS/MS) identified the 37/67 kDa high-affinity laminin receptor protein and nucleolin as a potential JEV-binding proteins. These proteins were subsequently investigated for a contribution to JEV entry to mouse microglial BV-2 cells together with other possible candidate receptor molecules including Hsp70, Hsp90, GRP78, CD14, and CD4. In antibody mediated inhibition of infection experiments, both anti-laminin receptor and anti-CD4 antibodies significantly reduced virus entry while anti-Hsp70 and 90 antibodies produced a slight reduction. Significant inhibition of virus entry (up to 80%) was observed in the presence of lipopolysaccharide (LPS) which resulted in a complete down-regulation of CD4 and moderate down-regulation of CD14. These results suggest that multiple receptor proteins may mediate the entry of JEV to microglial cells, with CD4 playing a major role.
Insights
Japanese encephalitis virus (JEV) enters microglial cells via multiple receptors. CD4 plays a significant role in JEV entry, highlighting potential therapeutic targets for viral encephalitis.
Area of Science:
- Neurovirology
- Immunology
Background:
- Japanese encephalitis virus (JEV) causes viral encephalitis in Asia.
- Microglia, immune cells in the central nervous system, may act as JEV reservoirs.
- Viral entry into host cells is crucial for tissue tropism.
Purpose of the Study:
- Identify molecules involved in JEV entry into microglial cells.
- Investigate the role of candidate receptor proteins in JEV infection of microglia.
Main Methods:
- Virus overlay protein-binding assay (VOPBA) and liquid chromatography-mass spectrometry (LC/MS/MS) identified JEV-binding proteins.
- Antibody-mediated inhibition assays tested the role of candidate receptors (laminin receptor, nucleolin, Hsp70, Hsp90, GRP78, CD14, CD4) in JEV entry.
- Lipopolysaccharide (LPS) was used to modulate CD4 and CD14 expression.
Main Results:
- The 37/67 kDa high-affinity laminin receptor and nucleolin were identified as potential JEV-binding proteins.
- Anti-laminin receptor and anti-CD4 antibodies significantly reduced JEV entry into microglial cells.
- LPS treatment inhibited JEV entry by up to 80%, down-regulating CD4 and CD14 expression.
Conclusions:
- Multiple receptor proteins mediate JEV entry into microglial cells.
- CD4 plays a major role in JEV entry into microglia.
- Targeting these receptors may offer therapeutic strategies against JEV infection.
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction

